Close
Nordic 9Nordic 9

Life Science Angels (investor - Venture Capital)

United States lifescienceangels.com
See something wrong or missing? Let us know
Offices:San Francisco
Average round investment:8M USD
Average number per year:1.0
Distribution: 2022 (1)
Portfolio companies: Netherlands InnoSIGN
Mostly invests in: Netherlands Netherlands (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Life Science Angels

Name Criteria
Netherlands Thuja Capital Management B.V.
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands Borski Fund
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
France Advent France Biotechnology
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Broadview Ventures
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain Ekarpen
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Belgium Gemma Frisius Fund
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Longwall Ventures
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Israel Nadav Rosenberg
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Peppermint Venture Partners
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Siparex
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top